We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Investigational Oral Regimen for Hepatitis C Shows Promise in NIH Trial

Side effects minimized with combination therapy in hard-to-treat patients.

Scientists Discover New Biological Marker for Parkinson's Disease

Researchers discover new biological indicator to track Parkinson’s disease using powerful MRI scanners.

Cellectricon Announces Project Grant Winners

The grant was awarded for project proposals utilizing Cellectricon’s Cellaxess ACE technology for the delivery of non-genetic material to adherent cells and cultures.

Aesica Unveils a New High Capacity Manufacturing Facility

New facility specifically built to produce a solid dose medication for treating Type 2 diabetes in adults.

NIH Begins Testing H7N9 Avian Influenza Vaccine Candidate

Researchers at nine sites nationwide have begun testing an investigational H7N9 avian influenza vaccine in humans.

Diagnoplex SA and Unilabs Sign a Collaboration Agreement

Agreement to market the Colox® non-invasive colon cancer screening test.

Syrris Releases Flow Chemistry Applications Video

Video demonstrates how diverse application are benefitting from Asia Flow Chemistry systems.

Biologists Find New Method for Discovering Antibiotics

Biologists have developed a revolutionary new method for identifying and characterizing antibiotics.

Kiadis Pharma Completes Five-year Follow-up of its Phase I/II Clinical Study with Blood Cancer Product ATIR™

67% survival demonstrated after 5 years and no transplant related mortalities.

Diabetes Drug May Reverse Alzheimer's and Enters Major Clinical Trial

A commonly prescribed diabetes drug could reverse memory loss and the build-up of plaques on the brain linked to Alzheimer's.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter